ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in

Mei Zhang1, Donald Fraser, Aled Phillips

  • 1Institute of Nephrology, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN UK. phillipsao@cf.ac.uk.

Insights

Transforming growth factor-beta1 (TGF-beta1) autoinduction in kidney proximal tubular cells involves independent Smad and MAP kinase pathways. These pathways regulate distinct TGF-beta1 mRNA and protein synthesis steps, crucial for renal fibrosis.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Transforming growth factor-beta1 (TGF-beta1) is a key mediator in progressive renal disease fibrosis.
  • Proximal tubular cells (PTCs) play a significant role in renal fibrosis.
  • The autoinduction mechanism of TGF-beta1 in PTCs requires further elucidation.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying TGF-beta1 autoinduction in proximal tubular cells.
  • To identify the signaling pathways involved in TGF-beta1 synthesis regulation.
  • To differentiate the roles of Smad and MAP kinase pathways in TGF-beta1 production.

Main Methods:

  • Treatment of PTCs with TGF-beta1.
  • Analysis of TGF-beta1 mRNA and protein synthesis.
  • Assessment of R-Smad phosphorylation and MAP kinase activation (ERK, p38).
  • Utilized dominant-negative Smad3 (Smad3 DN) and small interfering RNA (siRNA) for Smad3.
  • Employed chemical inhibitors PD98059 (ERK) and SB203580 (p38).
  • Investigated transcription factor activation (AP-1, NF-kappaB).

Main Results:

  • TGF-beta1 stimulation increased TGF-beta1 mRNA and de novo protein synthesis.
  • TGF-beta1 activated R-Smads, ERK, and p38 MAP kinase pathways independently.
  • Smad3 and ERK pathways were essential for TGF-beta1 mRNA upregulation.
  • Smad3 blockade inhibited AP-1 activation; PD98059 inhibited NF-kappaB activation.
  • p38 MAP kinase inhibition reduced de novo TGF-beta1 protein synthesis but not mRNA levels or transcription factor activation.

Conclusions:

  • TGF-beta1 autoinduction in PTCs is a complex process requiring coordinated, independent Smad and non-Smad (MAP kinase) pathways.
  • The Smad pathway regulates TGF-beta1 transcription (via AP-1), while ERK and p38 pathways influence mRNA and protein synthesis, respectively.
  • These findings highlight distinct regulatory roles in TGF-beta1 production, offering potential therapeutic targets for renal fibrosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...